Lecanemab, sold under the name Leqembi, is a monoclonal antibody therapy for Alzheimer's disease that clears toxic amyloid ...

Lecanemab, sold under the name Leqembi, is a monoclonal antibody therapy for Alzheimer's disease that clears toxic amyloid ...

T-Mobile is taking Black Friday to the next level, offering nearly $2000 in savings with an Apple Bundle and even more ways to save this season. Starting tomorrow, Nov. 26, new and existing customers, ...

Psyence Biomedical (PBM) announced the launch of a new psilocybin longevity research initiative in collaboration with leading researchers in South ...

Thus, the MHI’s Women’s Heart Health Fund was launched. “The goal is to raise $25 million by 2030,” Rochette says. “The Women ...

Detailed price information for Pasithea Therapeutics Corp WT (KTTAW-Q) from The Globe and Mail including charting and trades.

MATELASER, INC., an FDA-certified U.S. manufacturer of therapeutic laser systems, today announced the crowdfunding debut of its W1 REGEN Series, including W1 REGEN and W1 REGEN ULTRA. Weighing only 24 ...

Booster Therapeutics, a biotechnology company pioneering a new class of proteasome activator medicines to treat neurodegenerative and other diseases, announced today it has received a research grant ...

Detailed price information for Fate Therapeutics (FATE-Q) from The Globe and Mail including charting and trades.

AT&T, in collaboration with Boldyn Networks (Boldyn), today announced the launch of 5G cellular service in the Metropolitan ...